Response of authors to Ganju and Dias' comments on 'Inclusion of Placebos and Blinding for Ascending Dose First‐in‐Human Studies and Other Underpowered Phase 1 Studies Has Not Been Justified and on Balance is Not Useful' by D. A. Parasrampuria and L. Z. Benet. Issue 6 (4th October 2015) - Parasrampuria, Dolly A.